- NuVasive
-
NuVasive, Inc. Type Public (NASDAQ: NUVA) Industry Medical Technology Founded 1997 Headquarters San Diego, California Key people Alexis Lukianov (Chairman and CEO) Products Medical Devices Revenue $154.3 million (2007) Employees 350 (2007) Website http://www.nuvasive.com/ NuVasive, Inc. (NASDAQ: NUVA) based in San Diego, California, is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders.[1] NuVasive is a publicly traded company and is listed on the NASDAQ under the symbol NUVA.
NuVasive’s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products.
MAS combines three categories of NuVasive’s current product offerings: NeuroVision, a proprietary software-driven nerve avoidance system; MaXcess, a unique split-blade design retraction system; and specialized implants. The MAS platform enables procedures such as XLIF, or eXtreme Lateral Interbody Fusion, a minimally disruptive spine surgery that accesses the spine through the patient’s side.
References
External links
Categories:- Companies listed on NASDAQ
- Companies established in 1997
Wikimedia Foundation. 2010.
